The clinical utility of blood-based biomarkers of Alzheimer's disease: Triumphs and pitfalls.
International review of neurobiology · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansAlzheimer DiseaseBiomarkerstau ProteinsAmyloid beta-PeptidesGlial Fibrillary Acidic ProteinNeurofilament ProteinsAlzheimer’s diseaseAmyloid-β ratioBiomarker integrationBlood-based biomarkersClinical utilityEarly diagnosisGlial fibrillary acidic proteinNeurodegenerationNeurofilament light chainPhosphorylated tau
Come citare questo studio
Mohammad Muzaffar Mir, Gulzar Muzaffar Mir, Abdul Majid, Muffarah Hamid Alharthi, Abdullah M Alshahrani. (2026). The clinical utility of blood-based biomarkers of Alzheimer's disease: Triumphs and pitfalls.. International review of neurobiology. DOI: 10.1016/bs.irn.2026.05.008
Consulta la pubblicazione originale ↗